Patents

US 12433853 B2: Rationally designed lawsone derivatives as antimicrobials against multidrug-resistant Staphylococcus aureus

Granted
2025-10-07
Filed
2020-08-26 application 17637581
Type
Utility · 8 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Naphthoquinone derivatives of Lawsone have been found to be effective against Staphylococcus aureus and methicillin resistant Staphylococcus aureus (MRSA). Such compounds generally contain a substituent group at the 3-position of a specific naphthoquinone compound, i.e. 2-hydroxy-1,4-naphthoquinone. One of these derivatives referred to as compound 6c in the series exhibits potent antimicrobial activity that is comparable to that of the two commercial antibiotics ofloxacin and ciprofloxacin against the two strains of methicillin sensitive Staphylococcus aureus (MSSA; ATCC 29213 and ATCC 6538). In the case of two strains of MRSA (ATCC BAA-44 and ATCC BAA-1717) that have developed drug resistance to both ofloxacin and ciprofloxacin, the antimicrobial activity of 6c can almost rival that of vancomycin and daptomycin. Furthermore, 6c is also effective against vancomycin-intermediate and daptomycin non-susceptible strain of MRSA (ATCC 700699). Besides the efficacy, 6c has a much improved drug resistance profile in comparison with the conventional antibiotics.

Source: PVGPATDIS, file of 2026-04-10 (ipg251007.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Kent State University 139 patentsUS state governmentKent, OHKENT STATE UNIVERSITY Federal lobbying client EXACT high confidence: identical full name and state
KENT STATE UNIVERSITY Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Min Ho KimHudson, OH105PVGPATDIS, file of 2026-04-10
Songping D. HuangKent, OH5PVGPATDIS, file of 2026-04-10
Ronghui SongPittsburgh, PA1PVGPATDIS, file of 2026-04-10
Bing YuValley Forge, PA15PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/122PVGPATDIS, file of 2026-04-10
C07CAcyclic or carbocyclic compoundsC07C50/32PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/04PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2025-12-18Other
License
KENT STATE UNIVERSITY signed 2025-09-23NATIONAL INSTITUTES OF HEALTH BETHESDA, MD73258/540ECORSEXC, file of 2026-09-25
2022-02-23Assignment
Assignment of assignor's interest
KIM, MIN-HO signed 2022-02-11
YU, BING signed 2022-02-11
HUANG, SONGPING D signed 2022-02-15
SONG, RONGHUI signed 2022-02-16
KENT STATE UNIVERSITY KENT, OH59075/208ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.